We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Biomarker for Prostate Cancer

By HospiMedica staff writers
Posted on 08 Nov 2004
An in vitro diagnostics (IVD) monoclonal antibody called P504s can help confirm the diagnosis of prostate cancer.

P504s can detect cancer in samples obtained from prostatectomies, needle biopsies, and transurethral prostate resections. More...
The antibody shows strong cytoplasmic granular staining in prostate cancer. It positively stains prostatic cancer cells, premalignant lesions of the prostate, high-grade intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia. The P504s protein is expressed in malignant prostate tissues, and only weakly, if at all, in benign prostatic tissue. The staining in each case is easily distinguishable.

P504s is available from Signet Laboratories, Inc. (Dedham, MA, USA), whose stated mission is to create novel diagnostics and drugs for patients at risk for cancer, sepsis and renal failure, neurodegenerative diseases such as Alzheimer's, and prion diseases such as mad cow disease.

"P504s is a highly sensitive and specific marker for prostate carcinoma with demonstrated use in detecting and clearly marking malignant tissues and atypical prostate biopsies,” stated Angela Thomas, immunohistochemistry (IHC) product manager for Signet Laboratories.




Related Links:
Signet Laboratories

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.